Journal article

2-CHLORODEOXYADENOSINE INDUCES DURABLE REMISSIONS AND PROLONGED SUPPRESSION OF CD4( ) LYMPHOCYTE COUNTS IN PATIENTS WITH HAIRY-CELL LEUKEMIA

JF SEYMOUR, R KURZROCK, EJ FREIREICH, EH ESTEY

BLOOD | W B SAUNDERS CO | Published : 1994

Abstract

A number of effective treatments are available for patients with hairy cell leukemia (HCL). 2-Chlorodeoxyadenosine (2-CdA) induces more than 80% complete responses, but is associated with profound suppression of CD4+ lymphocyte counts. However, the duration of each is uncertain. We have analyzed a previously reported cohort of 40 patients who had responded to 2-CdA. Eight patients (20%) have relapsed at a median of 16 months (range, 3 to 23 months). The remaining 32 patients were observed for a median of 30 months (range, 7 to 43 months). No patients have died. At 3 years, the actuarial disease-free survival rate is 77% (95% confidence interval, 70% to 84%). The median CD4+ lymphocyte count ..

View full abstract